Trilogy International Partners (TRL) Stock Price, News & Analysis

Company Overview

Trilogy International Partners Inc., together with its subsidiaries, provides wireless voice and data communications services in New Zealand, Bolivia, and internationally. It offers prepaid and postpaid payment plans, including local, international long distance, and roaming services to customers and international visitors roaming on its networks. The company also provides fixed broadband communications to residential and enterprise customers, as well as a range of mobile and fixed line services in New Zealand and Australia; and fixed public telephony and wireless broadband services in Bolivia. As of December 31, 2021, it had a distribution network of approximately 13 company owned stores, 170 dealers, and 8,300 other dealer points of presence in Bolivia; and a distribution network of approximately 20 company owned retail stores, 40 independent dealers, and 2,500 points of sale through national retail chains and grocery stores in New Zealand. The company's services cover an aggregate population of 16.8 million users. It also provides services through its online self-service store in New Zealand; and operates under the Viva brand name in Bolivia. Trilogy International Partners Inc. was founded in 1982 and is headquartered in Bellevue, Washington.

Key Stats

• Today's Range: N/A
• 50-Day Range: C$0.24 to C$0.24
• 52-Week Range: N/A
• Volume: 239,293 shs
• Average Volume: 68,686 shs
• Market Capitalization: C$21.27 million
• P/E Ratio: 0.04
• Dividend Yield: 704.17%
• Price Target: N/A
• Consensus Rating: N/A

TRL Stock Analysis - Frequently Asked Questions

How do I buy shares of Trilogy International Partners?

Shares of TRL stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Trilogy International Partners own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Millicom International Cellular (TIGO), Emera (EMA), Merck & Co., Inc. (MRK), NFI Group (NFI), (ONCYF) (ONCYF) and ARK Autonomous Technology & Robotics ETF (ARKQ).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Drug Manufacturers - Major
• Sub-Industry: Healthcare
• Current Symbol: TSE:TRL
• Previous Symbol: TSE:AQX.A
• CUSIP: N/A
• CIK: N/A
• Web: N/A
• Phone: +1-425-4585900
• Fax: N/A
• Employees: 70,000
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 0.04
• Forward P/E Ratio: N/A
• P/E Growth: 0.86
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.92
• Quick Ratio: 3.87

Sales & Book Value

• Annual Sales: C$407.64 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 0.77
• Book Value: C$0.38 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 88,628,000
• Free Float: N/A
• Market Cap: C$21.27 million
• Optionable: Not Optionable
• Beta: N/A